Product Images Xifaxan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Xifaxan NDC 69189-0309 by Avera Mckennan Hospital, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a medication called Rifaximin, also known as Xifaxan. It comes in the form of a 200mg tablet manufactured by Salix Pharm with the lot number NWHF. The medication has been assigned a hospital lot number of APF15E07-AA and has an expiration date of 05/06/2016. The National Drug Code (NDC) for this medication is 6918903091. The medication is associated with the Avera McKennan hospital in Sioux Falls, South Dakota.*
This appears to be a description of a study design for a trial involving different treatments and phases. The design includes screening, treatment phases, maintenance phases, and follow-up phases. There is also mention of obtaining a daily/weekly symptom diary. Further information is not available.*
This appears to be a graph or chart displaying data related to a study or clinical trial involving a medication called XIFAXAN. The graph shows the proportion of patients without breakthrough HE over time (measured in days post-randomization), with a hazard ratio of 0.421 and a 95% confidence interval. Additional information may be available in the original source material.*
The text describes a graph showing the proportion of patients who did not require hospitalization related to hepatic encephalopathy (HE) over time. The graph shows data for two groups, one of which was given a placebo. The hazard ratio and confidence interval are also provided, along with a p-value. The graph covers a period of time from day 0 (post-randomization) to an unclear endpoint.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.